Curacle Appoints Dr. Wonil Lee as New Head of Drug Research Institute
[Asia Economy Reporter Lee Gwan-joo] Curacle announced on the 2nd that it has recruited Dr. Lee Won-il as the head of the new drug research institute to accelerate the development of new pipelines.
Dr. Lee graduated from the College of Pharmacy at Seoul National University and obtained his master's and doctoral degrees from the same graduate school. Since 2001, he has led the development of treatments and anticancer drugs for various diseases such as diabetes, COPD, gout, and atopic dermatitis at JW C&C New Drug Research Institute, GemVax & Kael, Jeil Pharmaceutical, and Daewon Pharmaceutical.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
A Curacle official stated, "With the recruitment of Dr. Lee, who has over 20 years of new drug development research experience, we expect to accelerate the development of vascular therapeutics based on the Solvadis platform and Curacle's emerging anticancer drug candidates CU04 and CU05." He added, "We also anticipate active exploration and research on new pipelines."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
